Delivery Order SPE2DB24D8003-SPE2DB25FJVBP
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,229.69 firm fixed price delivery order is for the supply of 100 units of the medication lisdexamfetamine 60 mg capsules. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,333.36 firm fixed-price contract is for the delivery of 4,568,201,145 units of Lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of May 12, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.84, is for the delivery of 4,567,372,214 lisdexamfetamine 40 mg capsules, to be completed by February 26, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a contract number of SPE2DB24D8002|SPE2DB25FJNDD, is for the delivery of 4,567,235 units of 50 mg lisdexamfetamine capsules. The contract has a firm fixed-price delivery order type with a ceiling value of $1,350.58 and a completion date of February 12, 2025. Dakota Drug, Inc. is also the holder of a significant single-award Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of lisdexamfetamine 50 mg capsules, a pharmaceutical product. The contract has a ceiling value of $2,326.86 and a completion date of December 18, 2024. This contract is not set aside for any special designation. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,000.64, is for the delivery of 4566862011 - LISDEXAMFETAMINE 40 MG CAPSULE 100S to support U.S. Armed Forces medical operations. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. It is not a set-aside contract. Dakota Drug, Inc. is a key supplier for the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 18 mg tablets (100-count units) valued at $3,142.26. This firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and carries no set-aside designation. The award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT...
- The Defense Logistics Agency (DLA) awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Methylphenidate ER 54 mg tablets (100 count) with a ceiling value of $2,055.10. This firm fixed price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, with no set-aside designation applied. The contract represents a direct fulfillment of pharmaceutical supply requirements under Dakota Drug's...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,161.78, is for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of July 18, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a Delivery Order valued at $2,159.71 for the supply of VYVANSE 40 MG CAPSULE 100S. The contract has an Ultimate Completion Date of June 23, 2025 and is a Firm Fixed Price arrangement. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001,...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJVBPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,011.46 to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota, for the supply of Lisdexamfetamine 50 mg capsules (100-count units). This firm fixed price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries no set-aside designation. The award is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, which is valued at $999,999,999 and extends through December 31, 2025. Dakota Drug, Inc. serves as a critical supplier in the federal pharmaceutical and medical equipment marketplace, with extensive experience delivering medications and healthcare products to support U.S. Armed Forces medical operations. The company holds a significant single-award IDC enabling it to provide a comprehensive range of pharmaceutical products and medical supplies to various defense healthcare facilities. This delivery order for Lisdexamfetamine, a prescription medication commonly used in attention deficit treatment, exemplifies the company's ongoing role in supplying essential pharmaceutical products to military medical infrastructure through the DLA Troop Support Medical procurement vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/21/25 |